1. HMG-CoA Reductase Inhibitors in the Prevention of Stroke

   • Annette H. M. van Mil
   • Rudi G. J. Westendorp
   • Gerard J. Blauw

   Leading Article 15 October 2012 Pages: 1 - 6

   

2. Oxazolidinones

   • Daniel J. Diekema
   • Ronald N. Jones

   Leading Article 15 October 2012 Pages: 7 - 16

   

3. Advances in Non-Nicotine Pharmacotherapy for Smoking Cessation

   • Lirio S. Covey
   • Maria A. Sullivan
   • David P. Adams

   Review Article 15 October 2012 Pages: 17 - 31

   

4. Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders

   • Gordon J. Lees

   Review Article 15 October 2012 Pages: 33 - 78

   

5. An Evaluation of Pharmacological Strategies for the Prevention and Treatment of Acute Renal Failure

   • Michael K. Dishart
   • John A. Kellum

   Disease Management 15 October 2012 Pages: 79 - 91

   

6. Pituitary Disorders

   • John J. Orrego
   • Ariel L. Barkan

   Disease Management 15 October 2012 Pages: 93 - 106

   

7. Ganirelix

   • Peter S. Gillies
   • Diana Faudas
   • Caroline M. Perry

   Adis New Drug Profile 15 October 2012 Pages: 107 - 111

   

8. Ganirelix

   • Thomas Strowitzki

   Adis New Drug Profile 15 October 2012 Pages: 112 - 112

9. Ganirelix

   • Victor Y. Fujimoto

   Adis New Drug Profile 15 October 2012 Pages: 112 - 113

10. Moxifloxacin

    • Julia A. Barman Balfour
    • Harriet M. Lamb

    Adis Drug Evaluation 15 October 2012 Pages: 115 - 139

    

11. Felodipine/Metoprolol

    • Malini Haria
    • Greg L. Plosker
    • Anthony Markham

    Adis Drug Evaluation 15 October 2012 Pages: 141 - 157